Chief Legal Counsel Anna Hörnlund, who wrote a letter in this week's The Lancet, says Macchiarini's work needed to obtain
ethical approval from one of six regional
ethical review boards, as
required by Swedish law — and neither Macchiarini nor his former employer, Karolinska Institutet, did so: